We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Novel Organoid Culture System Used for Brain Cell Research

By LabMedica International staff writers
Posted on 24 Apr 2017
Print article
Image: Human stem cells derived from skin samples have been induced to form tiny, three-dimensional, brain-like cultures that behave similarly to cells in the human midbrain (Photo courtesy of the University of Luxembourg).
Image: Human stem cells derived from skin samples have been induced to form tiny, three-dimensional, brain-like cultures that behave similarly to cells in the human midbrain (Photo courtesy of the University of Luxembourg).
Brain cells - derived from pluripotent stem cells - growing in culture assemble into three-dimensional (3D), brain-like structures (organoids) that can serve as an experimental model system for studies into the cellular biology of the normal and diseased brain.

Research on human brain development and neurological diseases has been limited by the lack of advanced experimental in vitro models that truly recapitulate the complexity of the human brain. In an effort to resolve this dilemma, investigators at the University of Luxembourg used a precisely defined cocktail of growth factors and a novel treatment method to drive pluripotent stem cells to develop into a robust human brain organoid system that was highly specific to the midbrain. These human midbrain organoids contained spatially organized groups of dopaminergic neurons, which made them an attractive model for the study of Parkinson’s disease.

The investigators characterized the neuronal, astroglial, and oligodendrocyte differentiation of the midbrain organoids in detail in the April 13, 2017, online edition of the journal Stem Cell Reports. In addition, they demonstrated the presence of synaptic connections and electrophysiological activity. The complexity of this model was further highlighted by the myelination of neurites.

"Our cell cultures open new doors to brain research," said senior author Dr. Jens Schwamborn, professor of developmental and cellular biology at the University of Luxembourg. "We can now use them to study the causes of Parkinson's disease and how it could possibly be effectively treated. Our subsequent examination of these artificial tissue samples revealed that various cell types characteristic of the midbrain had developed. The cells can transmit and process signals. We were even able to detect dopaminergic cells - just like in the midbrain."

"On our new cell cultures, we can study the mechanisms that lead to Parkinson's much better than was ever the case before, "said Dr. Schwamborn." We can test what effects environmental impacts such as pollutants have on the onset of the disease, whether there are new active agents that could possibly relieve the symptoms of Parkinson's, or whether the disease could even be cured from its very cause. We will be performing such investigations next."

The investigators have established a biotech company, Braingineering Technologies Sarl to explore the commercial potential of brain organoid cultures for research and drug development.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.